DK1291343T3 - Hydroxyformamidin-derivater og lægemidler indeholdende disse - Google Patents

Hydroxyformamidin-derivater og lægemidler indeholdende disse

Info

Publication number: DK1291343T3
Authority: DK; Denmark
Prior art keywords: group; formula; substituted; represented; participates
Prior art date: 2000-06-15

Application number

DK01941061T

Other languages

English (en)

Inventor

Masakazu Sato

Noriyuki Miyata

Takaaki Ishii

Yuko Kobayashi

Hideaki Amada

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-15

Filing date

2001-06-15

Publication date

2007-02-05

2001-06-15 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2007-02-05 Application granted granted Critical

2007-02-05 Publication of DK1291343T3 publication Critical patent/DK1291343T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DK01941061T 2000-06-15 2001-06-15 Hydroxyformamidin-derivater og lægemidler indeholdende disse DK1291343T3 (da)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2000180477		2000-06-15
JP2000180479		2000-06-15
JP2000336140		2000-11-02
JP2000359781		2000-11-27
PCT/JP2001/005108 WO2001096309A1 (fr)	2000-06-15	2001-06-15	Derives hydroxyformamidine et medicaments les contenant

Publications (1)

Publication Number	Publication Date
DK1291343T3 true DK1291343T3 (da)	2007-02-05

Family

ID=27481364

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01941061T DK1291343T3 (da)	2000-06-15	2001-06-15	Hydroxyformamidin-derivater og lægemidler indeholdende disse

Country Status (13)

Country	Link
US (1)	US6670382B2 (da)
EP (1)	EP1291343B1 (da)
JP (1)	JP4904659B2 (da)
KR (1)	KR100776095B1 (da)
CN (1)	CN1177824C (da)
AT (1)	ATE347546T1 (da)
AU (2)	AU7453501A (da)
CA (1)	CA2411418C (da)
DE (1)	DE60125036T2 (da)
DK (1)	DK1291343T3 (da)
ES (1)	ES2280379T3 (da)
HK (1)	HK1057043A1 (da)
WO (1)	WO2001096309A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2280379T3 (es)	2000-06-15	2007-09-16	Taisho Pharmaceutical Co., Ltd	Derivados de la hidroxiformamidina y medicinas que lo contienen.
CN1272313C (zh) *	2001-04-26	2006-08-30	大正制药株式会社	20－羟基二十碳四烯酸生成抑制剂
GB2376609B (en) *	2001-05-02	2003-06-18	Symbian Ltd	Group communication method for a wireless communication device
WO2003022821A1 (fr) *	2001-09-06	2003-03-20	Taisho Pharmaceutical Co., Ltd.	Derive d'heterocycle presentant une activite inhibitrice de l'enzyme de production du 20-hete
WO2004024677A1 (ja)	2002-09-12	2004-03-25	Taisho Pharmaceutical Co.,Ltd.	Ｎ−ヒドロキシホルムアミジン誘導体
ES2814200T3 (es) *	2005-07-29	2021-03-26	Basf Se	Estabilización de productos para el cuidado del cuerpo y del hogar contra la degradación por radiación UV utilizando derivados de merocianina
CA2677949C (en) *	2007-02-22	2016-02-09	Paul Anthony Worthington	Iminipyridine derivatives and their uses as microbiocides
AU2017220454A1 (en) *	2016-02-15	2018-08-09	Taisho Pharmaceutical Co., Ltd.	Azole-substituted pyridine compound

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3998970A (en) *	1975-04-28	1976-12-21	Stauffer Chemical Company	N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
US3959368A (en)	1975-04-28	1976-05-25	Stauffer Chemical Company	N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
GB1594261A (en)	1977-02-18	1981-07-30	Shell Int Research	Benzyloxime ethers
US4079149A (en)	1977-06-30	1978-03-14	Shell Oil Company	Benzyl oxime ethers
IL56878A (en)	1978-03-31	1984-03-30	Rhone Poulenc Inc	Ketoximinoethers and their use as insecticides
US4158015A (en)	1978-08-16	1979-06-12	Mobil Oil Corporation	Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
DE2907972A1 (de)	1979-03-01	1980-09-11	Bayer Ag	Omega -halogen-acetophenon-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als zwischenprodukte zur herstellung von omega -azolyl-acetophenon-oximethern
AU6159680A (en)	1979-08-24	1981-04-09	Rhone-Poulenc, Inc.	Ketoximinoether insecticides
DE3005899A1 (de)	1980-02-16	1981-09-03	Hoechst Ag, 6000 Frankfurt	Derivate des 1,2,4-triazols und imidazols, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
DE3044564A1 (de)	1980-11-26	1982-07-15	Basf Ag, 6700 Ludwigshafen	Verfahren zur herstellung von (alpha)-bromacetophenonoximethern
US4474815A (en)	1981-04-30	1984-10-02	Commonwealth Scientific And Industrial Research Organization	Insecticidal oximes
US4566901A (en)	1982-05-06	1986-01-28	Ciba-Geigy Corporation	Novel oxime ethers, the preparation thereof, compositions containing them and the use thereof
US4434182A (en)	1982-11-01	1984-02-28	Fmc Corporation	Insecticidal substituted-biphenylmethyl oxime ethers
IL75858A (en)	1984-07-31	1989-02-28	Commw Scient Ind Res Org	Substituted benzyl ethers of oximes,their production and their use as arthropodicides
US4824476A (en)	1985-06-24	1989-04-25	Ciba-Geigy Corporation	Herbicidally active derivatives of N-phenyl-3,4,5,6-tetrahydrophthalimide
DE4213149A1 (de) *	1992-04-22	1993-10-28	Hoechst Ag	Akarizide, insektizide und nematizide substituierte (Hetero)-Aryl-Alkyl-ketonoxim-O-ether, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US5267857A (en)	1993-02-12	1993-12-07	A-Dec, Inc.	Brightness control system for dental handpiece light
ATE315932T1 (de) *	1999-11-01	2006-02-15	Taisho Pharmaceutical Co Ltd	Hemmer für das 20-hete-produzierende enzym
ES2280379T3 (es)	2000-06-15	2007-09-16	Taisho Pharmaceutical Co., Ltd	Derivados de la hidroxiformamidina y medicinas que lo contienen.
CN1272313C (zh) *	2001-04-26	2006-08-30	大正制药株式会社	20－羟基二十碳四烯酸生成抑制剂

2001
- 2001-06-15 ES ES01941061T patent/ES2280379T3/es not_active Expired - Lifetime
- 2001-06-15 CA CA002411418A patent/CA2411418C/en not_active Expired - Fee Related
- 2001-06-15 US US10/311,003 patent/US6670382B2/en not_active Expired - Fee Related
- 2001-06-15 AT AT01941061T patent/ATE347546T1/de active
- 2001-06-15 AU AU7453501A patent/AU7453501A/xx active Pending
- 2001-06-15 CN CNB018110126A patent/CN1177824C/zh not_active Expired - Fee Related
- 2001-06-15 EP EP01941061A patent/EP1291343B1/en not_active Expired - Lifetime
- 2001-06-15 DE DE60125036T patent/DE60125036T2/de not_active Expired - Lifetime
- 2001-06-15 WO PCT/JP2001/005108 patent/WO2001096309A1/ja active IP Right Grant
- 2001-06-15 JP JP2002510452A patent/JP4904659B2/ja not_active Expired - Fee Related
- 2001-06-15 AU AU2001274535A patent/AU2001274535B2/en not_active Ceased
- 2001-06-15 DK DK01941061T patent/DK1291343T3/da active
- 2001-06-15 KR KR1020027016921A patent/KR100776095B1/ko not_active IP Right Cessation
2003
- 2003-12-23 HK HK03109324A patent/HK1057043A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1177824C (zh)	2004-12-01
KR20030010690A (ko)	2003-02-05
HK1057043A1 (en)	2004-03-12
ATE347546T1 (de)	2006-12-15
AU7453501A (en)	2001-12-24
CN1436173A (zh)	2003-08-13
CA2411418C (en)	2010-01-12
US6670382B2 (en)	2003-12-30
EP1291343A4 (en)	2004-04-07
EP1291343A1 (en)	2003-03-12
DE60125036T2 (de)	2007-06-21
ES2280379T3 (es)	2007-09-16
DE60125036D1 (de)	2007-01-18
JP4904659B2 (ja)	2012-03-28
KR100776095B1 (ko)	2007-11-15
WO2001096309A1 (fr)	2001-12-20
US20030186979A1 (en)	2003-10-02
CA2411418A1 (en)	2002-12-06
EP1291343B1 (en)	2006-12-06
AU2001274535B2 (en)	2005-06-30

Similar Documents

Publication	Publication Date	Title
BRPI9908319B1 (pt)	2012-01-10	composto amino cìclico, composição farmacêutica, medicamento contendo um composto amino cìclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cìclico ou um sal farmacologicamente aceitável do mesmo.
EA200900358A1 (ru)	2009-10-30	Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
NO20085060L (no)	2008-12-03	Triazolpyrazinderivater anvendelige som anti-cancermidler
KR890012649A (ko)	1989-09-18	아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법
NO884202L (no)	1989-03-28	Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater.
ATE288443T1 (de)	2005-02-15	Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
IT1228293B (it)	1991-06-07	Benzoderivati di composti eterociclici contenenti azoto.
DK1291343T3 (da)	2007-02-05	Hydroxyformamidin-derivater og lægemidler indeholdende disse
ATE476431T1 (de)	2010-08-15	Piperidin- und azetidinderivate als glyt1- inhibitoren
DE60137442D1 (de)	2009-03-05	5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
DE69910083D1 (de)	2003-09-04	Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
DE69510582D1 (de)	1999-08-12	Purinderivate und ihre pharmazeutisch akzeptablen Salze
DE69620175D1 (de)	2002-05-02	Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
DK630186A (da)	1987-07-01	Pyrimido(5,4-b)(1,4)oxazinderivater, tautomer, tautomerblandinger og syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
TH84545A (th)	2007-05-17	สารรักษาโรค
TH75469A (th)	2006-02-09	อนุพันธ์แอซิลอะมิโนไธแอโซล, ยาปรุงสำเร็จและการประยุกต์ใช้เชิงบำบัดของอนุพันธ์เหล่านั้น
ATE316090T1 (de)	2006-02-15	Mmp-inhibitoren
UA48054A1 (uk)	2002-08-15	Діетиламіноетиламіду-5-метил-2-(1,3,4-тіадіазоліл)-сукцинамінової кислоти гідрохлорид, який проявляє аналгетичну активність
TH20764A (th)	1996-09-24	อนุพันธ์เฮเทอโรไซคลิคของแอไซโลน
TH51768A (th)	2002-07-02	สารประกอบคาร์บาฟีเนม การใช้ของสารดังกล่าว และสารประกอบตัวกลางสำหรับสารดังกล่าว
TH53986A (th)	2002-11-22	ซัลโฟนิลออกซาโซลามีนชนิดใหม่
TH84863A (th)	2007-06-07	สารประกอบ, สารผสมที่มีสารเหล่านี้, การเตรียมสารเหล่านี้ และการใช้สารเหล่านี้
TH84547A (th)	2007-05-17	สารรักษาโรค